Seoul Medical Group — Medicare Advantage Spinal Diagnosis Fraud
Medicare Advantage Provider Pays Over $62 Million for Diagnosis Fraud
Source: U.S. Department of Justice
TL;DR: Medicare Advantage Provider Pays Over $62 Million for Diagnosis Fraud This case resulted in a $62 Million resolution and demonstrates the impact of whistleblower protections in recovering funds from fraud.
Summary
Seoul Medical Group, its subsidiary, its former president and majority owner, and an affiliated radiology group agreed to collectively pay over $62 million to resolve False Claims Act allegations that they fraudulently increased Medicare Advantage reimbursements by submitting inflated claims with severe spinal condition diagnosis codes for patients who did not have these conditions. DOJ alleged the defendants systematically upcoded diagnoses to inflate risk scores and increase payments from CMS.
Our Take
Diagnosis upcoding cases in radiology often involve interpretation practices that consistently find severe conditions regardless of clinical reality. Insiders may have access to interpretation templates, quality review findings, comparison data showing unusual diagnosis rates, and communications about revenue expectations tied to specific diagnosis codes. If you've seen radiologists pressured to "find" conditions that maximize reimbursement, preserve the evidence of how interpretations were guided and reviewed.
Read the full article from the original source:
View Original ArticleOpens in a new tab. Content from U.S. Department of Justice.
Notice
The summaries above are based on publicly available information released by the U.S. Department of Justice and are provided for informational purposes only. They do not constitute legal advice, investigative findings, or allegations by Disclosure Strategy. Our commentary reflects general, experience-based observations about how False Claims Act matters commonly arise and is not a statement about any party's liability.